Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
Recruiting · NCT07220252 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis | Relapsing Multiple Sclerosis | Recruiting | Phase 2 / Phase 3 | 2026-09-21 | NCT07220252 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| TG Therapeutics, Inc. | 16 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| TG Therapeutics Investigational Trial Site | Gdansk | Poland | 1 |
| TG Therapeutics Investigational Trial Site | Warsaw | Poland | 1 |
| TG Therapeutics Investigational Trial Site | Poznan | Poland | 1 |